|By PR Newswire||
|October 17, 2007 06:06 PM EDT||
SAN FRANCISCO, Oct. 17 /PRNewswire/ -- Collaborative Drug Discovery, Inc. (CDD, Inc.) has captured extensive literature data from six years of recent publications focused on the fight against Chagas' disease. Now for the first time these data are available to researchers free of charge, via the CDD Database.
Sources include the Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, the Journal of American Chemical Society, Journal of Ethnopharmacology, Proceedings of the National Academy of Sciences (PNAS), International Journal of Antimicrobial Agents, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Molecular and Biochemical Parasitology, Journal of Inorganic Biochemistry, Acta Topical, and Experimental Parasitology.
The data sets captured include 574 compound structures and just over 350 different enzyme, cell, animal, and toxicity based protocols. The data are conveniently organized so scientists can easily mine for hits, sub-structural motifs or keywords and obtain the original literature reference for more detailed analysis.
These data sets will help researchers better prioritize compounds to test experimentally and build superior models to guide experiments.
This project is the first of a series literature data capture projects focused on drug discovery research into neglected infectious diseases. In addition to literature data, community members also provide open access to some of their experimental results either pre- or post-publication. The CDD global community includes leading researchers from four continents.
To submit other datasets, capabilities, expertise, or models which would be valuable to the Chagas' or neglected disease community, please contact us at [email protected].
A significant subset of all the community data -- and a range of other data sets such as Chagas' data -- is available openly to the public at no cost. For this historical set of data either visit http://www.collaborativedrug.com/registrations/new or e-mail [email protected] to register for the username and password to the open data sets.
About Collaborative Drug Discovery: CDD is the world's first platform for selectively sharing collaborative drug discovery data. Scientists working with the CDD community platform can pool their research in order to more effectively develop new drug candidates for commercial and humanitarian markets. Conceived in 2003, and formally launched in 2004, Collaborative Drug Discovery (CDD) has been serving the collaborative data needs of researchers for years. The CDD global community includes hundreds of scientists from leading research foundations, academia and industry. A subset of the data is available openly to the public at no cost. For more information, please visit http://www.collaborativedrug.com/.Collaborative Drug Discovery, Inc.
CONTACT: Barry A. Bunin, PhD, President of Collaborative Drug Discovery,
Inc., +1-650-204-3084, [email protected]
There is little doubt that Big Data solutions will have an increasing role in the Enterprise IT mainstream over time. Big Data at Cloud Expo - to be held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA - has announced its Call for Papers is open. Cloud computing is being adopted in one form or another by 94% of enterprises today. Tens of billions of new devices are being connected to The Internet of Things. And Big Data is driving this bus. An exponential increase is...
Sep. 29, 2016 08:00 AM EDT Reads: 2,708
Internet of @ThingsExpo has announced today that Chris Matthieu has been named tech chair of Internet of @ThingsExpo 2016 Silicon Valley. The 6thInternet of @ThingsExpo will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Sep. 29, 2016 08:00 AM EDT Reads: 2,644
An IoT product’s log files speak volumes about what’s happening with your products in the field, pinpointing current and potential issues, and enabling you to predict failures and save millions of dollars in inventory. But until recently, no one knew how to listen. In his session at @ThingsExpo, Dan Gettens, Chief Research Officer at OnProcess, will discuss recent research by Massachusetts Institute of Technology and OnProcess Technology, where MIT created a new, breakthrough analytics model f...
Sep. 29, 2016 08:00 AM EDT Reads: 2,083
Sep. 29, 2016 07:15 AM EDT Reads: 1,727
Sep. 29, 2016 07:00 AM EDT Reads: 2,936
Sep. 29, 2016 07:00 AM EDT Reads: 3,483
Sep. 29, 2016 07:00 AM EDT Reads: 3,412
Sep. 29, 2016 07:00 AM EDT Reads: 2,274
Sep. 29, 2016 06:45 AM EDT Reads: 1,672
Sep. 29, 2016 06:45 AM EDT Reads: 3,180
Sep. 29, 2016 06:15 AM EDT Reads: 1,472
Sep. 29, 2016 06:00 AM EDT Reads: 2,761
Sep. 29, 2016 06:00 AM EDT Reads: 2,679
Sep. 29, 2016 06:00 AM EDT Reads: 525
Sep. 29, 2016 05:45 AM EDT Reads: 1,052